Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer
European Journal of Cancer · 2026-08 · 244 · 116902
DOI: 10.1016/j.ejca.2026.116902 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2026-08. Verfasst von Kinnosuke Matsumoto und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, the University of Osaka, Osaka, Japan. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Interstitial, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, the University of Osaka, Osaka, Japan.
- Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, the University of Osaka, Osaka, Japan. Electronic address: takayuki.s12@hotmail.co.jp.
- Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, the University of Osaka, Osaka, Japan; Department of Thoracic Oncology, NHO Osaka Toneyama Medical Center, Osaka, Japan.
- Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
- Department of Internal Medicine, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.
- Department of Thoracic Oncology, NHO Osaka Toneyama Medical Center, Osaka, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Matsumoto, K., Yamamoto, Y., Shiroyama, T., Kuge, T., Miyazaki, A., Komuta, K., Tamiya, M., Nishino, K., Tsukaguchi, A., Tamiya, A., Mihashi, Y., Uchida, J., Mori, M., Yamauchi, K., Suzuki, H., Kinehara, Y., Moritomo, K., Shoshihara, N., Machiyama, H., …, & Kumanogoh, A. (2026). Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer. European Journal of Cancer, 244, 116902. https://doi.org/10.1016/j.ejca.2026.116902
Vancouver
Matsumoto K, Yamamoto Y, Shiroyama T, Kuge T, Miyazaki A, Komuta K, et al. Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer. European Journal of Cancer. 2026;244:116902. doi:10.1016/j.ejca.2026.116902
BibTeX
@article{Matsumoto2026,
author = {Matsumoto, Kinnosuke and Yamamoto, Yuji and Shiroyama, Takayuki and Kuge, Tomoki and Miyazaki, Akito and Komuta, Kiyohide and Tamiya, Motohiro and Nishino, Kazumi and Tsukaguchi, Akihiro and Tamiya, Akihiro and Mihashi, Yasuhiro and Uchida, Junji and Mori, Masahide and Yamauchi, Keijiro and Suzuki, Hidekazu and Kinehara, Yuhei and Moritomo, Koki and Shoshihara, Nao and Machiyama, Hirotomo and Kanaoka, Kensuke and Tobita, Satoshi and Ueno, Kiyonobu and Niki, Toshie and Tetsumoto, Satoshi and Nishikawa, Yuki and Morimura, Osamu and Kato, Soichiro and Yoneda, Midori and Azuma, Koji and Osa, Akio and Minami, Toshiyuki and Nagatomo, Izumi and Takeda, Yoshito and Kumanogoh, Atsushi},
title = {Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer},
journal = {European Journal of Cancer},
year = {2026},
volume = {244},
pages = {116902},
doi = {10.1016/j.ejca.2026.116902}
}
EUVIMED